His primary areas of study are Psychiatry, Antipsychotic, Bipolar disorder, Young adult and Pediatrics. His Schizophrenia study in the realm of Psychiatry interacts with subjects such as Accidental. His research links Mood with Antipsychotic.
His Bipolar disorder research focuses on Quetiapine and how it connects with Randomized controlled trial. The Young adult study combines topics in areas such as Retrospective cohort study and Obstetrics. His Pediatrics research includes elements of Nausea, Antidepressant medication and Discontinuation.
The scientist’s investigation covers issues in Psychiatry, Bipolar disorder, Internal medicine, Depression and Major depressive disorder. His Psychiatry study incorporates themes from Tolerability and Pediatrics. His Bipolar disorder research is multidisciplinary, relying on both Quetiapine and Clinical psychology, Mood.
His biological study spans a wide range of topics, including Schizoaffective disorder, Endocrinology, Olanzapine and Atypical antipsychotic. The Depression study combines topics in areas such as Medical prescription and Comorbidity. His Major depressive disorder research also works with subjects such as
His main research concerns Internal medicine, Major depressive disorder, Depression, Citalopram and Bipolar disorder. The study incorporates disciplines such as Treatment-resistant depression and Oncology in addition to Internal medicine. He is investigating Endocrinology and Psychiatry as part of his examination of Depression.
William V. Bobo works on Psychiatry which deals in particular with Depressive symptoms. His work deals with themes such as Venlafaxine and Escitalopram, which intersect with Citalopram. His Bipolar disorder research is multidisciplinary, incorporating perspectives in Generalized anxiety disorder and Clinical psychology, Mood.
William V. Bobo mostly deals with Internal medicine, Body mass index, Bipolar disorder, Depression and Citalopram. His study in Body mass index is interdisciplinary in nature, drawing from both Binge eating, Treatment-resistant depression and Intravenous ketamine. He has included themes like Polypharmacy, Generalized anxiety disorder, Unmeasured confounding and Medication adherence in his Bipolar disorder study.
His Depression research entails a greater understanding of Psychiatry. His Citalopram study integrates concerns from other disciplines, such as Confounding, Escitalopram and Serotonin reuptake inhibitor. His Escitalopram research is multidisciplinary, incorporating elements of Major depressive disorder and Pharmacogenomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: